
Pharma Business - March 3, 2015
Novo Nordisk Adjusts IPO Price
Novo Nordisk is adjusting to the indicative offer price range for the initial public offering (IPO) of NNIT A/S on Nasdaq Copenhagen as further described in the offering circular, which was published on Feb. 23, 2015. According to the company, “The adjustment to the initial indicative offer price range reflects higher than expected investor demand for […]

Intellectual Property - February 10, 2015
Novo to Seek IPO for NNIT
Novo Nordisk A/S is seeking an Initial Public Offering (IPO) of NNIT A/S on NASDAQ OMX Copenhagen A/S (Nasdaq Copenhagen). NNIT is a wholly-owned subsidiary of Novo Nordisk A/S and one of Denmark’s leading IT service providers and consultancies. The company has been considering spinning off NNIT since last January, when it named a new […]